Use of low-molecular-weight heparins for the prevention and treatment of cerebral edemas
US6579858B1 · kind B1 · utility
0Cited by
0References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 29, 1999 |
| Grant date | Jun 17, 2003 |
| Priority date | — |
| Expiry date | Nov 29, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Cerebral edema is prevented and treated by administering an effective amount of a low molecular weight heparin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.